Approval for New Factory Construction Finalized
Phased Operations to Begin Next Year

On July 3, LivesMed announced that it has obtained approval from Yongin Special City for the construction of a new factory on a site in Giheung-gu and will begin full-scale development of its advanced manufacturing facility, 'AMF.' With this permit finalized, the company will commence practical work to enable phased operations starting in 2027.


At the Yongin AMF, LivesMed will produce its entire product lineup, ranging from its flagship multi-joint laparoscopic surgical instrument ArtiSential (ArtiSentialTM) to its next-generation surgical robot system STARK (STARKTM). After unveiling its global launch roadmap for STARK in May, which prioritizes entry into the Korean, Japanese, and U.S. markets, the company now aims to establish a stable supply base for future market expansion of STARK through the AMF.

Exterior view of Livesmed AMF, Yongin, Gyeonggi Province. Livesmed

Exterior view of Livesmed AMF, Yongin, Gyeonggi Province. Livesmed

View original image

Furthermore, leveraging this advanced production base, LivesMed plans to establish a global integrated hub connecting its technology and products to the world. For the first time among domestic surgical instrument companies, LivesMed will set up its own global training center within a Korean manufacturing site, rather than overseas or at external institutions, and will operate integrated clinical education, demonstration, and technology collaboration programs for medical professionals and partners worldwide.



Jungjoo Lee, CEO of LivesMed, stated, "AMF is not only the foundation for delivering the technological capabilities that LivesMed has accumulated over the past 15 years to the global market in a stable manner, but also a space to share our technology with medical professionals and partners around the world. We will make AMF a key hub that elevates LivesMed's global presence to the next level."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing